New Bolton Center Kennett Square, PA
Emergencies & Appointments:
Ryan Hospital Philadelphia, PA


Research Assistant Professor of Immuno-Biology, University of Pennsylvania School of Veterinary Medicine
Contact Information:

Atherton, M. J., Rotolo, A., Haran, K. P., Mason, N. J. Case report: Clinical and serological hallmarks of cytokine release syndrome in a canine B cell lymphoma patient treated with autologous CAR-T cells Front Vet Sci 9: 824982, 2022.

Mason, N. J., Chester, N., Xiong, A., Rotolo, A., Wu, Y., Yoshimoto, S., Glassman, P., Gulendran, G., Siegel, D. L. Development of a fully canine anti-canine CTLA4 monoclonal antibody for comparative translational research in dogs with spontaneous tumors MAbs 13: 2004638, 2021.

Rotolo, A., Atherton, M. J., Kasper, B. T., Haran, K. P., Mason, N. J. Genetic re-direction of canine primary T cells for clinical trial use in pet dogs with spontaneous cancer STAR Protoc 2: 100905, 2021.

Rotolo, A., Chabannon, C., Gramignoli, R. Identification of hurdles in the development of cell-based therapies Cytotherapy 22: 53-56, 2020.

Rotolo, A., Karadimitris, A., Ruella, M. Building upon the success of CART19: chimeric antigen receptor T cells for hematologic malignancies Leuk Lymphoma 59: 2040-2055, 2018.

Rotolo, A., Caputo, V. S., Holubova, M., Baxan, N., Dubois, O., Chaudhry, M. S., Xiao, X., Goudevenou, K., Pitcher, D. S., Petevi, K., Kachramanoglou, C., Iles, S., Naresh, K., Maher, J., Karadimitris, A. Enhanced anti-lymphoma activity of CAR19-iNKT cells underpinned by dual CD19 and CD1d targeting Cancer Cell 34: 596-610 e11, 2018.

Rotolo, A., Caputo, V., Karadimitris, A. The prospects and promise of chimeric antigen receptor immunotherapy in multiple myeloma British Journal of Haematology 173: 350-64, 2016.

Chaidos, A., Caputo, V., Gouvedenou, K., Liu, B., Marigo, I., Chaudhry, M. S., Rotolo, A., Tough, D. F., Smithers, N. N., Bassil, A. K., Chapman, T. D., Harker, N. R., Barbash, O., Tummino, P., Al-Mahdi, N., Haynes, A. C., Cutler, L., Le, B., Rahemtulla, A., Roberts, I., Kleijnen, M., Witherington, J. J., Parr, N. J., Prinjha, R. K., Karadimitris, A. Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762 Blood 123: 697-705, 2014.

Marchioli, R., Finazzi, G., Specchia, G., Cacciola, R., Cavazzina, R., Cilloni, D., De Stefano, V., Elli, E., Iurlo, A., Latagliata, R., Lunghi, F., Lunghi, M., Marfisi, R. M., Musto, P., Masciulli, A., Musolino, C., Cascavilla, N., Quarta, G., Randi, M. L., Rapezzi, D., Ruggeri, M., Rumi, E., Scortechini, A. R., Santini, S., Scarano, M., Siragusa, S., Spadea, A., Tieghi, A., Angelucci, E., Visani, G., Vannucchi, A. M., Barbui, T., Cyto-Pv Collaborative Group Cardiovascular events and intensity of treatment in polycythemia vera New England Journal of Medicine 368: 22-33, 2013.

Marin, D., Rotolo, A., Milojkovic, D., Goldman, J. The next questions in chronic myeloid leukaemia and their answers Current Opinion in Hematology 20: 163-8, 2013.

Cilloni, D., Messa, E., Rotolo, A., Saglio, G. Emerging drugs for chronic myeloid leukemia Expert Opin Emerg Drugs 15: 175-84, 2010.

Messa, E., Carturan, S., Maffe, C., Pautasso, M., Bracco, E., Roetto, A., Messa, F., Arruga, F., Defilippi, I., Rosso, V., Zanone, C., Rotolo, A., Greco, E., Pellegrino, R. M., Alberti, D., Saglio, G., Cilloni, D. Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging Haematologica 95: 1308-16, 2010.

Nicoli, P., Bosa, M., Rotolo, A., Cilloni, D., Saglio, G. Herpetic leg paralysis and abdominal ileus in a patient with idiopathic myelofibrosis Internal and Emergency Medicine 4: 65-6, 2009.

Nicoli, P., Defilippi, I., Carturan, S., Roetto, A., Messa, F., Arruga, F., Messa, E., Rotolo, A., Iacobucci, I., Bracco, E., Saglio, G., Cilloni, D. Detection of humoral immune responses against WT1 antigen in patients affected by different hematological malignancies Acta Haematologica 120: 47-50, 2008.